These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35096509)

  • 21. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine.
    Saharia KK; Husson JS; Niederhaus SV; Iraguha T; Avila SV; Yoo YJ; Hardy NM; Fan X; Omili D; Crane A; Carrier A; Xie WY; Vander Mause E; Hankey K; Bauman S; Lesho P; Mannuel HD; Ahuja A; Mathew M; Avruch J; Baddley J; Goloubeva O; Shetty K; Dahiya S; Rapoport AP; Luetkens T; Atanackovic D
    Clin Transl Immunology; 2022; 11(5):e1391. PubMed ID: 35505864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza vaccination in solid-organ transplant recipients.
    Cordero E; Manuel O
    Curr Opin Organ Transplant; 2012 Dec; 17(6):601-8. PubMed ID: 23042206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients.
    Loconsole D; Stea ED; Sallustio A; Fontò G; Pronzo V; Simone S; Centrone F; Accogli M; Gesualdo L; Chironna M
    Vaccines (Basel); 2021 Jul; 9(8):. PubMed ID: 34451931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic.
    Nimmo A; Gardiner D; Ushiro-Lumb I; Ravanan R; Forsythe JLR
    Transplantation; 2022 Jul; 106(7):1312-1329. PubMed ID: 35404911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumococcal vaccination in adult solid organ transplant recipients: A review of current evidence.
    Dendle C; Stuart RL; Mulley WR; Holdsworth SR
    Vaccine; 2018 Oct; 36(42):6253-6261. PubMed ID: 30217523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine.
    Abravanel F; Marion O; Del Bello A; Beunon T; Romieu-Mourez R; Couat C; Pucelle M; Staes L; Guitard J; Esposito L; Faguer S; Kamar N; Izopet J
    Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35334985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
    Thuluvath PJ; Robarts P; Chauhan M
    J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.
    Meshram HS; Kute V; Rane H; Dave R; Banerjee S; Mishra V; Chauhan S
    Transpl Infect Dis; 2022 Dec; 24(6):e13926. PubMed ID: 35924679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune Response to SARS-CoV-2 Vaccine among Heart Transplant Recipients: A Systematic Review.
    Shoar S; Prada-Ruiz ACC; Patarroyo-Aponte G; Chaudhary A; Sadegh Asadi M
    Clin Med Insights Circ Respir Pulm Med; 2022; 16():11795484221105327. PubMed ID: 35693423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Third Dose of the COVID-19 Vaccine among Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis.
    Efros O; Anteby R; Halfon M; Meisel E; Klang E; Soffer S
    Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 vaccination in pediatric solid organ transplant recipients-Current state and future directions.
    L'Huillier AG; Ardura MI; Chaudhuri A; Danziger-Isakov L; Dulek D; Green M; Michaels MG; Posfay-Barbe KM; Vàsquez L; Benden C
    Pediatr Transplant; 2021 Sep; 25(6):e14031. PubMed ID: 34076928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review.
    Filippidis P; Vionnet J; Manuel O; Mombelli M
    Expert Rev Anti Infect Ther; 2022 May; 20(5):663-680. PubMed ID: 34854329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients.
    Marion O; Del Bello A; Abravanel F; Faguer S; Esposito L; Laure Hebral A; Bellière J; Izopet J; Kamar N
    Transplant Direct; 2022 Jan; 8(1):e1248. PubMed ID: 34966837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis.
    Alotaibi AS; Shalabi HA; Alhifany AA; Alotaibi NE; Alnuhait MA; Altheaby AR; Alhazmi AY
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
    Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discordance Between SARS-CoV-2-specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients.
    Fernández-Ruiz M; Almendro-Vázquez P; Carretero O; Ruiz-Merlo T; Laguna-Goya R; San Juan R; López-Medrano F; García-Ríos E; Más V; Moreno-Batenero M; Loinaz C; Andrés A; Pérez-Romero P; Paz-Artal E; Aguado JM
    Transplant Direct; 2021 Dec; 7(12):e794. PubMed ID: 34805496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
    Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients.
    Phadke VK; Scanlon N; Jordan SC; Rouphael NG
    Curr Transplant Rep; 2021; 8(2):127-139. PubMed ID: 33688459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
    Kremsner PG; Ahuad Guerrero RA; Arana-Arri E; Aroca Martinez GJ; Bonten M; Chandler R; Corral G; De Block EJL; Ecker L; Gabor JJ; Garcia Lopez CA; Gonzales L; Granados González MA; Gorini N; Grobusch MP; Hrabar AD; Junker H; Kimura A; Lanata CF; Lehmann C; Leroux-Roels I; Mann P; Martinez-Reséndez MF; Ochoa TJ; Poy CA; Reyes Fentanes MJ; Rivera Mejia LM; Ruiz Herrera VV; Sáez-Llorens X; Schönborn-Kellenberger O; Schunk M; Sierra Garcia A; Vergara I; Verstraeten T; Vico M; Oostvogels L;
    Lancet Infect Dis; 2022 Mar; 22(3):329-340. PubMed ID: 34826381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.